These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16201929)

  • 1. Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae.
    Kim NJ; Park SJ; Choi SH; Lee MS; Choo EJ; Kwak YG; Woo JH; Ryu J; Jeong JY; Kim YS
    Microb Drug Resist; 2005; 11(3):260-5. PubMed ID: 16201929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.
    Morosini MI; Cantón R; Loza E; Negri MC; Galán JC; Almaraz F; Baquero F
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2427-31. PubMed ID: 11502509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
    Van Eldere J; Meekers E; Lagrou K; Massonet C; Canu A; Devenyns I; Verhaegen J; Syrogiannopoulos G; Leclercq R
    Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey.
    Sener B; Köseoglu O; Gür D; Bryskier A
    J Chemother; 2005 Feb; 17(1):31-5. PubMed ID: 15828441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.
    Montanari MP; Mingoia M; Giovanetti E; Varaldo PE
    J Clin Microbiol; 2001 Apr; 39(4):1311-5. PubMed ID: 11283047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations.
    Zhanel GG; Johanson C; Hisanaga T; Mendoza C; Laing N; Noreddin A; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2004 Dec; 54(6):1072-7. PubMed ID: 15531596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study].
    Gür D; Mülazimoğlu L; Unal S;
    Mikrobiyol Bul; 2007 Jan; 41(1):1-9. PubMed ID: 17427547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and macrolide resistance phenotypes and genotypes among clinical isolates of Streptococcus pneumoniae collected in Sofia, Bulgaria from 2001 to 2005.
    Setchanova LP; Ouzounova-Raykova V; Zhelezova GZ; Mitov IG
    J Chemother; 2007 Jun; 19(3):256-62. PubMed ID: 17594919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of antiribosomal agents on penicillin-susceptible and -resistant Streptococcus pneumoniae in relation to their resistance genotypes.
    Sener B; Köseoglu O
    Int J Antimicrob Agents; 2004 Jul; 24(1):39-42. PubMed ID: 15225859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.
    Hoban DJ; Wierzbowski AK; Nichol K; Zhanel GG
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2147-50. PubMed ID: 11408241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of novel 2-fluoro-naphthyridine-containing ketolides.
    Abbanat D; Webb G; Foleno B; Li Y; Macielag M; Montenegro D; Wira E; Bush K
    Antimicrob Agents Chemother; 2005 Jan; 49(1):309-15. PubMed ID: 15616310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci].
    Saribaş Z; Tunçkanat F; Ozçakir O; Ercis S
    Mikrobiyol Bul; 2010 Apr; 44(2):177-86. PubMed ID: 20549951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.
    Wierzbowski AK; Boyd D; Mulvey M; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4635-40. PubMed ID: 16251306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study.
    Schito GC; Marchese A; Elkharrat D; Farrell DJ;
    J Chemother; 2004 Feb; 16(1):13-22. PubMed ID: 15077994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: the in vitro activity of telithromcycin versus comparators.
    Shackcloth J; Williams L; Farrell DJ
    J Infect; 2004 Apr; 48(3):229-35. PubMed ID: 15001301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
    Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.